Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Tertomotide |
| Synonyms | |
| Therapy Description |
Tertomotide (GV1001) is a 16-amino acid peptide of human telomerase reverse transcriptase (hTERT) that may induce immune response against hTERT-expressing ccancer cells (PMID: 23295993), and can also act as a ligand for gonadotropin-releasing hormone receptor (GnRHR) and thus inhibit prostate cancer cell growth (PMID: 30400054). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Tertomotide | GV1001|GV-1001|GV 1001|PrimoVax | Tertomotide (GV1001) is a 16-amino acid peptide of human telomerase reverse transcriptase (hTERT) that may induce immune response against hTERT-expressing ccancer cells (PMID: 23295993), and can also act as a ligand for gonadotropin-releasing hormone receptor (GnRHR) and thus inhibit prostate cancer cell growth (PMID: 30400054). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|